Belgian biotech Confo raises $65 million

Confo Therapeutics, a Belgian firm developing small molecules and antibodies that target G protein–coupled receptors, aims to start testing its drug candidates in humans with the help of $65 million in series B financing. The company plans to bring two medicines through Phase 1 clinical trials and get two more ready for the clinic, including molecules that target the receptor GPR75 for weight loss. Confo has previously partnered with Eli Lilly & Co. and Daiichi Sankyo.

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-08-05
DOI
https://doi.org/10.1021/cen-10224-buscon17
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Belgian biotech Confo raises $65 million

Rowan Walrath
C&EN Global Enterprise
Pharmaceutical studies and practices
article

Belgian biotech Confo raises $65 million

Rowan Walrath
article en

Abstract

Confo Therapeutics, a Belgian firm developing small molecules and antibodies that target G protein–coupled receptors, aims to start testing its drug candidates in humans with the help of $65 million in series B financing. The company plans to bring two medicines through Phase 1 clinical trials and get two more ready for the clinic, including molecules that target the receptor GPR75 for weight loss. Confo has previously partnered with Eli Lilly & Co. and Daiichi Sankyo.

C&EN Global EnterpriseVol. 102(24)
Openalex Percentile: Top 81%
Pharmaceutical studies and practices
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Belgian biotech Confo raises $65 million — Rowan Walrath · C&EN Global Enterprise (2024) | TGRS Research Map | TGRS